A Double-Blind Endoscopic Study with De-Nol® Tablets and Cimetidine for Duodenal Ulcer

Abstract

In a double-blind, double-dummy comparison of short-term ulcer healing, involving 50 patients treated with either De-Nol® tablets (four times daily) or Cimetidine tablets (400 mg. twice daily), no statistical difference in healing rates was observed after 8 weeks' treatment. There was, however, a numerical trend in favour of De-Nol (De-Nol. 100% healed; Cimetidine, 88% healed). Statistical significance in favour of De-Nol was observed, however, in the reduction of antacid tablet consumption and relief of ulcer pain. No unwanted side effects were observed with either drug. This trial indicates that De-Nol and cimetidine are equally effective and useful in the short-term treatment of duodenal ulcer.

Key words:

• Cimetidine
• De-Nol chewing tablets
• duodenal ulcer